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 T-MSCs were isolated from the thymus
gland of new born pigs, expanded,
characterized and seeded onto a
commercially available scaffold.
 The seeded-grafts were cultured within a
bioreactor and then used to reconstruct
the RVOT of a growing swine model.
 Pigs were followed up for 4.5 months;
then scanned with a cardiac magnetic
resonance and terminated to harvest the
implants.
 By comparing the outcome of the seeded-
grafts to the unseeded-ones used as
control, we observed a reduced ﬁbrosis
and an improved RVOT strain, cardiac
remodeling and endothelialization.https://doi.org/10.1016/j.jacbts.2019.02.001
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365SUMMARY
AB BAND ACRONYM S
CM = cardiomyocyte
cMYH = cardiac myosin heavy
chain
Cx-43 = connexin-43
DMEM = Dulbecco’s modiﬁed
Eagle’s medium
EC = endothelial cell
FBS = fetal bovine serum
IL = interleukinGraft cellularization holds great promise in overcoming the limitations associated with prosthetic materials
currently used in corrective cardiac surgery. In this study, the authors evaluated the advantages of graft cel-
lularization for right ventricular outﬂow tract reconstruction in a novel porcine model. After 4.5 months from
implantation, improved myocardial strain, better endothelialization and cardiomyocyte incorporation, and
reduced ﬁbrosis were observed in the cellularized grafts compared with the acellular grafts. To the authors’
knowledge, this is the ﬁrst demonstration of successful right ventricular outﬂow tract correction using
bioengineered grafts in a large animal model. (J Am Coll Cardiol Basic Trans Science 2019;4:364–84)
© 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).4 = isolectin B4IsoBMSC = mesenchymal stem cell
PBS = phosphate-buffered
saline
PS = penicillin/streptomycin
RT = room temperature
RV = right ventricular
RVOT = right ventricular
outﬂow tract
RVOT-MS = fractional area of
change in the right ventricular
outﬂow tract
SIS-ECM = small intestinal
submucosa–derived
extracellular matrix
T-MSC = thymus-derived
mesenchymal stem cell
VMSC = vascular smooth
muscle cellC ardiac tissue engineering holds great prom-ise for deﬁnitive correction of congenitalheart disease. By seeding cells on a biode-
gradable scaffold, this approach is aimed at devel-
oping a viable graft capable of growing and
remodeling in parallel with the recipient’s organ.
Once implanted in vivo, an ideal biofunctional graft
is remodeled and eventually replaced by the host’s
own extracellular matrix (1). Several cell types have
been used for cardiac tissue engineering, including
mesenchymal stem cells (MSCs) (2), induced pluripo-
tent stem cells (3), endothelial cells (ECs) (4), and
pericytes (5). In particular, MSCs are a preferred
choice because of their immune-privileged nature,
multilineage differentiation potential, and ability to
promote tissue healing by paracrine mechanisms
(6,7). Furthermore, MSCs can be isolated from various
tissues and organs, including bone marrow, umbilical
cord, adipose tissue, and thymus (8,9). Infants who
undergo palliative cardiac surgery for tetralogy of
Fallot often have the thymus removed to facilitate ac-
cess to the heart. Hence, the explanted gland repre-
sents a convenient source of autologous MSCs for
use during deﬁnitive correction of congenital cardiac
defects.
To date, cardiac tissue engineering has been
applied principally to the reconstruction of pulmo-
nary arteries or valves, whereas problems associated
with the right ventricular outﬂow tract (RVOT)
remain an unmet clinical need. In fact, surgical
correction of RVOT obstruction is reportedly associ-
ated with the development of aneurysmal or akinetic
regions and an arrhythmogenic substrate (10). These
complications have long-term consequences for out-
comes in patients with tetralogy of Fallot (11).
In this paper, we report a controlled, randomized
study in growing female piglets, comparing the
feasibility, safety, and efﬁcacy of RVOT reconstruc-
tion using a graft made of small intestinal
submucosa–derived extracellular matrix (SIS-ECM) orthe same graft engineered using porcine
thymus-derived MSCs (T-MSCs).
METHODS
ANIMALS. Animals were treated in accor-
dance with the Guide for the Care and Use of
Laboratory Animals published by the National
Institutes of Health in 1996 and conforming to
the Animals (Scientiﬁc Procedures) Act of
1986. In vivo graft implantation was carried
out under United Kingdom Home Ofﬁce
project license PPL 30/3019.
ISOLATION AND EXPANSION OF T-MSCs. T-
MSCs were isolated from newborn female
piglets as previously described (2). Brieﬂy,
cells were mechanically and enzymatically
digested with collagenase I for 2 h at 37C. The iso-
lated cells were selected by adherence to plastic and
expanded until passages 3 to 5.
NEONATAL RAT CARDIOMYOCYTE ISOLATION.
Cardiomyocytes (CMs) were isolated from 1- to 3-day-
old Wistar rats (Charles River Laboratories, Wilming-
ton, Massachusetts). Three litters of neonatal rats
were killed by means of decapitation, according to
schedule 1 of the Animals (Scientiﬁc Procedures) Act.
The hearts were washed with 1% penicillin/strepto-
mycin (P/S) (Life Technologies, Carlsbad, California)
phosphate-buffered saline (PBS) (Life Technologies),
minced into thin pieces, and dissociated with 0.05%
trypsin and 0.02% ethylenediaminetetraacetic acid in
PBS for 15 min at 37C. Cell suspension was ﬁltered
using a 70-mm nylon mesh, and enzyme activity was
stopped with fetal bovine serum (FBS; Thermo Fisher
Scientiﬁc, Waltham, Massachusetts). A second diges-
tion was performed with 0.1% trypsin and 0.02%
ethylenediaminetetraacetic acid in PBS for 15 min at
37C, after which the cell fraction was ﬁltered and the
enzyme blocked with FBS. This procedure was
repeated 3 more times. Then the cell fractions were
TABLE 1 Antibodies for Immunohistochemistry
Primary Antibody
Primary Antibody
Dilution Manufacturer
Secondary
Antibody
Secondary Antibody
Dilution Manufacturer
Mouse anti–alpha–sarcomeric actinin 1:100 Abcam Goat antimouse–Alexa Fluor 488 1:400 Abcam
Mouse anti–alpha–smooth muscle actin 1:200 Abcam Goat antimouse–Alexa Fluor 488 1:400 Abcam
Mouse anti–cardiac myosin heavy chain 1:150 Thermo Fisher Scientiﬁc Goat antimouse–Alexa Fluor 488 1:400 Abcam
Rabbit anti–connexin-43 1:100 Santa Cruz Biotechnology Goat antirabbit–Alexa Fluor 546 1:400 Abcam
Mouse anti–discoidin domain receptor 2 1:100 Santa Cruz Biotechnology Goat antimouse–Alexa Fluor 488 1:400 Abcam
Isolectin B4-biotin 1:100 Life Technologies Streptavidin–Alexa Fluor 488 1:200 Life Technologies
Rabbit anti-Ki67 1:200 Abcam Goat antirabbit–Alexa Fluor 546 1:400 Abcam
Mouse anti–metalloproteinase 1 1:200 Abcam Goat antimouse–Alexa Fluor 488 1:400 Abcam
Mouse anti–smooth
muscle myosin heavy chain
1:100 Dako Goat antimouse-Cy3 1:300 Jackson ImmunoResearch
Laboratories
Primary antibodies used for immunoﬂuorescent staining and respective secondary antibodies used for detection.
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366pooled together and centrifuged for 5 min at 100g.
The resulting pellet was resuspended in low-glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM; Life
Technologies), seeded onto a T75 ﬂask and incubated
for 1 h in a humidiﬁed chamber at 37C in 5% CO2
(incubator) to allow as many ﬁbroblasts as possible to
attach to the plastic. The cell suspension was then
harvested, centrifuged, and resuspended into 1% FBS
and 1% P/S DMEM:M199 medium (Thermo Fisher
Scientiﬁc) in a ratio of 1:1 and seeded onto previously
coated plates with 0.1% gelatin (Sigma-Aldrich, St.
Louis, Missouri).
FLOW CYTOMETRY. Fluorescence-activated cell
sorting analysis was used to determine cell surface
marker expression. The protocol was performed as
described by Iacobazzi et al. (2). The following pri-
mary antibodies were used: 1:10 CD31-PE (Bio-Rad,
Hercules, California), 1:600 CD44-APC (Thermo
Fisher Scientiﬁc), 1:25 CD45-FITC (Bio-Rad), 1:10
CD73-APC (R and D Systems, Minneapolis, Minne-
sota), 1:20 CD90-PE (BioLegend, San Diego, Califor-
nia), and 1:5 CD105-PE (LSBio, Seattle, Washington).
Analysis was performed on a NovoCyte ﬂow cytome-
ter (ACEA Bioscience, San Diego, California) using
NovoExpress (ACEA Bioscience) for data collection
and FlowJo (TreeStar, Ashland, Ohio) for analysis.
IN VITRO MULTILINEAGE DIFFERENTIATION. Multi-
lineage differentiation into osteocytes, adipocytes,
and chondrocytes was performed with MSCs at pas-
sages between 3 and 5. Cells were cultured in alpha-
MEM medium with speciﬁc StemXVivo supplement
kits (R and D Systems) for different time points.
Osteogenic differentiation was assessed after 3 weeks
of culture using alizarin red (Sigma-Aldrich) to detect
calcium deposition. Oil red O staining (Sigma-Aldrich)
was used to detect lipid accumulation of cells un-
dergoing 2 weeks of adipogenic differentiation.
Alcian blue staining (Sigma-Aldrich) was used todetermine chondrogenic cartilage formation after 3
weeks of cell culture.
SIS-ECM CELLULARIZATION. Pieces of SIS-ECM
(CorMatrix Cardiovascular, Roswell, Georgia)
approximately 7 cm2 were soaked in DMEM for 24 h in
a 1% agarose (Sigma-Aldrich) coated plate. The scaf-
fold was then seeded with P3 swine T-MSCs at a
density of 5  105 cells/cm2 and cultured in growing
medium for 1 week under static conditions in an
incubator. The graft was then stitched to the rotating
arm of a InBreath bioreactor (Harvard Apparatus,
Cambridge, Massachusetts) and stitched back to itself
as to fashion a conduit shape with the cells facing the
outer side of the scaffold. The bioreactor chamber was
ﬁlled with growing medium and connected to a motor
platform placed at 37C in a CO2 incubator. The rota-
tion was initially set at 0.5 rpm and slowly increased
within 24 h to the ﬁnal speed of 2 rpm, which was
maintained for 1 week.
CELL VIABILITY. To determine cell viability on the
engineered scaffolds, a Live/Dead Viability/Cytotox-
icity Kit for mammalian cells (Thermo Fisher Scien-
tiﬁc) was used according to the manufacturer’s
instructions. Fluorescence imaging was carried out
using a Zeiss Axio Observer.Z1 with Zen Blue software
(Carl Zeiss, Oberkochen, Germany).
MECHANICAL TESTING. Unseeded and seeded SIS-
ECM pieces were analyzed for mechanical properties
using an Instron 3343B machine (Instron, Norwood,
Massachusetts) with pneumatic grips and a 100-N load
cell. Crosshead speed was set at 10 mm/min. Samples
were measured for tensile stress at maximum load and
Young’s modulus using Bluehill software (Instron).
SCANNING ELECTRON MICROSCOPY. Samples were
ﬁxed, washed, and completely dehydrated as previ-
ously described (2). Surface topography was imaged
using a Quanta 200 FEI ﬁeld emission scanning elec-
tron microscope (Thermo Fisher Scientiﬁc).
FIGURE 1 Phenotypic and Functional Characterization of Thymus-Derived Mesenchymal Stem Cells
(A) Flow cytometry representative histograms illustrate the expression of CD44, CD73, CD90, and CD105 and lack of endothelial and
hematopoietic markers on thymus-derived mesenchymal stem cells. (B) Bar chart showing the proportion of viable cells positive to the
investigated markers (n ¼ 4; mean  SE). (C) Multilineage differentiation of the cells into osteocytes, adipocytes. Nontreated cells were used
as negative controls.
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FIGURE 2 Biological and Mechanical Assessment of the Unseeded and Cell-Seeded Grafts
(A) Seeded graft (arrow) is mounted and cultured in a bioreactor. (B) Viable (L) and dead (D) cells attached to the seeded scaffold. Scanning
electron microscopic (SEM) images illustrate the topography of the unseeded graft and a conﬂuent layer of oriented cells growing on the
seeded sample. Scale bars, 100 mm. Hematoxylin and eosin (H and E) staining shows lack of nuclei in the unseeded scaffold and a multilayer of
cells in the seeded graft. Elastic van Gieson (EVG) staining conﬁrmed the capacity of the seeded cells to produce their own extracellular
matrix. Scale bars, 50 mm. (C) Young’s modulus and ultimate tensile strength of the unseeded and seeded grafts showed no signiﬁcant
differences between the 2 groups (n ¼ 4; mean  SE).
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FIGURE 3 in Vivo Right Ventricular Outﬂow Tract Reconstruction and Operated Animals Follow-Up
(A) Cartoon (i) and macroscopic image (ii) showing the site of the implant on the right ventricular outﬂow tract (RVOT). Gross analysis of the
explants after 4.5 months in vivo shows the epicardial (iii) and endocardial (iv) sides of the graft (dotted line). (B) The operated pigs
increased their body weight at a normal rate. (C) Doppler echocardiographic measurements of the right ventricle immediately before
termination demonstrate comparable RVOT diameter and maximum velocity (Vmax) in the operated animals and unoperated control (Ctr)
pigs. (D) Representative cardiac magnetic resonance images of right ventricular diastolic and systolic area (encircled in green) before
surgery and 4.5 months thereafter. The patches could be visualized as a small bump protruding from the right ventricle (arrows). (E) RVOT
myocardial strain measured at termination was greater in the animals implanted with seeded grafts. See Supplemental Video 1.
Continued on the next page
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FIGURE 3 Continued
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370For cell conﬂuence quantiﬁcation, ImageJ (Na-
tional Institutes of Health, Bethesda, Maryland) was
used on 1,000 images to measure the gaps between
cells. This area was converted into a proportion and
expressed as conﬂuence rather then emptiness.
IN VIVO STUDIES. A total of 13 female Landrace pig-
lets weighing 20 to 25 kg underwent cardiac surgery.
Four additional unoperated pigs weighing approxi-
mately 90 kg were used as internal controls. All sur-
gical procedures were performed under general
anesthesia (ketamine, midazolam, dexmedetomidine,
and isoﬂurane) and neuromuscular blockade (pan-
curonium bromide). The heart was exposed through a
median sternotomy, and cardiopulmonary bypass
was established by cannulating the inferior and su-
perior vena cavae and the ascending aorta. An inci-
sion approximately 4 cm in length was made over the
RVOT and below the pulmonary valve annulus,
leaving the valve intact. The cut created was then
patched with either regular SIS-ECM or T-MSC-seededSIS-ECM. The latter was implanted with seeded cells
facing the inner side of the heart. Ten swine were
randomized to treatment according to a controlled
study design. Details of the operation are reported in
Supplemental Video 1. Animals were allowed to
recover under continuous post-operative monitoring
for the initial 24 to 48 h. Analgesic agents (paraceta-
mol, morphine) and an antibiotic agent (cefuroxime)
were administered regularly during this period.
DOPPLER ECHOCARDIOGRAPHY. A 2-dimensional
echocardiographic assessment was performed under
general anesthesia using a 2-dimensional system
(VividQ, GE Healthcare, Little Chalfont, United
Kingdom) before graft implantation and 1, 2, 3, and
4.5 months thereafter.
CARDIAC MAGNETIC RESONANCE. Cardiac magnetic
resonance was performed under anesthesia using a 3-
T scanner (Siemens Healthcare, Erlangen, Germany).
Dedicated long-axis and short-axis cine imaging of
the RVOT was performed using steady-state free
TABLE 2 Doppler Echocardiographic Measurements
Pre-Operative Control
Post-Operative
Unseeded
Post-Operative
Seeded
IVSd (cm) 1.12  0.48 1.30  0.10 1.40  0.17 1.35  0.16
IVSs (cm) 0.89  0.08 2.10  0.10 1.60  0.17 2.00  0.22
LVIDd (cm) 2.82  0.12 3.40  0.23 3.43  0.46 3.72  0.14
LVIDs (cm) 1.96  0.13 1.75  0.27 1.70  0.44 2.10  0.07
LVPWd (cm) 0.85  0.06 1.20  0.11 1.36  0.20 1.62  0.11
LVPWs (cm) 1.37  0.10 2.25  0.15 2.16  0.03 2.15  0.12
EDV (ml) 31  3 49  8 50  15 59  5
ESV (ml) 12  2 11  3 10  6 14  1
EF (%) 60  5 80  6 83  6 76  4
SV (ml) 18  2 39  6 40  10 46  6
FS (%) 31.3  3.1 50.0  6.6 51.3  5.6 44.0  3.9
RV FAC (%) 48.97  5.41 50.80  2.88 49.16  2.89 47.11  3.5
Values are mean  SE. Left ventricular and RV function measured using electrocardiography before surgery and
4.5 months thereafter. Unoperated adult pigs were used as control subjects.
EDV ¼ end-diastolic volume; EF ¼ ejection fraction; ESV ¼ end-systolic volume; FAC ¼ fractional area change;
FS ¼ fractional shortening; IVSd ¼ intraventricular septum in diastole; IVSs ¼ interventricular septum in systole;
LVIDd ¼ left ventricular internal diameter in diastole; LVIDs ¼ left ventricular internal diameter in systole;
LVPWd ¼ left ventricular posterior wall diastole; LVPWs ¼ left ventricular posterior wall systole; RV ¼ right
ventricular; SV ¼ stroke volume.
TABLE 3 Cardiac Magnetic Resonance Imaging Measurements
Pre-Operative
Unoperated
Controls
Post-Operative
Unseeded
Post-Operative
Seeded
Diastolic area (cm2) 3.91  0.25 11.98  0.56 11.87  0.73 12.01  0.10
Systolic area (cm2) 1.96  0.22 6.03  0.40 6.48  0.45 5.68  0.21
Strain (%) 51  3 50  1.08 45.50  0.84* 52.63  2.17*
Values are mean  SE. Diastolic and systolic area and right ventricular outﬂow tract strain as assessed using
cardiac cardiac magnetic resonance before surgery (pre-operative) and 4.5 months thereafter (unseeded and
seeded animals). Unoperated adult pigs were used as control subjects. *p < 0.05 when comparing unseeded
control animals vs. unoperated control animals, and seeded vs. unseeded animals.
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371precession sequences. Biomechanical properties in
the RVOT were investigated by measuring the frac-
tional area of change in the RVOT (RVOT-MS) deﬁned
as follows: RVOT MS ¼ [RVOT short-axis area
(diastole)  RVOT short-axis area (systole)]/RVOT
short-axis area (diastole).
IN VIVO ENDPOINTS. The average in vivo follow-up
of 10 of the operated animals was 145  14 days,
corresponding to approximately 4.5 months. The
remaining 3 animals, all of them implanted with
T-MSC SIS-ECM, were terminated 24 h, 1 week,
and 2 weeks after implantation to determine the
persistence of seeded cells in the graft post-surgery.
Euthanasia was performed with an intravenous
injection of 150 mg/kg of pentobarbital sodium.
HISTOLOGY. Explanted samples were washed in PBS
and ﬁxed overnight with 4% paraformaldehyde at 4C.
Fixed tissues were processed in a Thermo Excelsior AS
(Thermo Fisher Scientiﬁc) and embedded with a
Thermo HistoStar (Thermo Fisher Scientiﬁc) machine.
Five-micrometer-thick sections were cut using a
Shandon Finesse 325 microtome (Thermo Fisher Sci-
entiﬁc). Hematoxylin and eosin, elastic van Gieson,
andMasson’s trichrome staining was performed either
manually or using a Shandon Varistain 24-4 (Thermo
Fisher Scientiﬁc) automated machine. Von Kossa
staining was carried out using a Silver plating kit
(In Vitro Diagnostic Medical Device, Darmstadt,
Germany) for the detection of microcalciﬁcation.
Fibrosis was evaluated by measuring the collagen
content of the explants in the Masson’s trichrome
staining. Results were expressed as proportion of area
occupied by collagen within the graft tissue.
FLUORESCENT IMMUNOHISTOCHEMISTRY. Parafﬁn-
embedded sections were deparafﬁnized by 2 changes
of clearene and rehydrated through an alcohol
gradient. A heated antigen retrieval with 10 mmol/l
citrate buffer (pH 6.0) was performed. Samples were
blocked with 10% goat serum (Sigma-Aldrich) in PBS
for 30 min at room temperature (RT) and incubated
with the unconjugated primary antibodies overnight
at 4C. A list of the primary and secondary antibodies
is provided in Table 1. Fluorophore-conjugated sec-
ondary antibodies were incubated on the sections for
1 h at RT in the dark. Nuclei were counterstained with
40,6-diamidino-2-phenylindole (1:1,000, Sigma-
Aldrich) for 10 min at RT. Slides were mounted with
Vectashield Hardset Mounting Medium (Vector Lab-
oratories, Burlingame, California). Images were taken
using a Zeiss Observer.Z1 ﬂuorescent microscope.
For microvasculature quantiﬁcation, 10 random
ﬁelds per section of the explanted grafts were
analyzed under 20 magniﬁcation of a ﬂuorescentmicroscope. Arterioles were quantiﬁed by counting
the number of a–smooth muscle actin–positive ves-
sels costained with isolectin B4 (IsoB4). Moreover,
the number of a–smooth muscle actin–negative,
IsoB4-positive vessels was counted to determine the
number of capillaries developed in the healing car-
diac tissue. The average number of arterioles and
capillaries was then divided by the total acquired
section area to calculate vascular density.
The graft regions composed of myocyte pockets
were identiﬁed immunohistochemically using cardiac
myosin heavy chain (cMYH) expression. Under a 20
magniﬁcation lens, 10 to 20 images were captured to
cover all the cMYH-positive areas that developed in
the newly formed tissue. Following identiﬁcation of
the regions containing CMs, ImageJ software was used
to quantify the remodeling of the tissue sections. The
images were split into individual channels. The
ImageJ function threshold was applied in the channel
of interest to convert each image to a binary version,
where pixels were classiﬁed as representing either a
FIGURE 4 Examination of the Explanted Grafts
(A,B) Hematoxylin and eosin (H and E) and Masson’s trichrome staining of the explants illustrates the collagen-rich grafts well integrated with the right
ventricle (RV). (C) Higher magniﬁcation images of the samples. H and E staining shows little remains of the scaffold (arrows) 4.5 months after im-
plantation (i,v). Masson’s trichrome staining demonstrates the presence of new muscle tissue (arrows) generated from the implanted grafts (ii,vi). Elastic
van Gieson staining illustrates an elastin-rich endothelium laying the inner side of the explants (iii,vii). No calciﬁcation was detected as shown by von
Kossa stain (iv,viii). (D)More abundance of collagen was detected in the unseeded samples in comparison with the seeded group. (E) Immunostaining for
matrix metalloproteinase 1 (MMP1) conﬁrmed that the extracellular matrix was undergoing remodeling processes, and no differences were observed
between the 2 groups. (F) Immunostaining and quantiﬁcation of the ﬁbrotic marker discoidin domain-containing receptor 2 (DDR2) (green ﬂuorescence)
showed more ﬁbrosis in the unseeded explants compared with the seeded ones. (G) Cells expressing cardiac myosin heavy chain (cMYH) were present in
explants from both groups, though more abundant in the seeded one. In addition, only the seeded graft contained cells double positive for cMYH and
connexin-43 (Cx-43). Scale bars, 50 mm. Dapi ¼ 40,6-diamidino-2-phenylindole; Iso ¼ isolectin B4.
Continued on the next page
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FIGURE 4 Continued
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374region of myocytes or a region not containing myo-
cytes. The pixels representing myocyte regions were
quantiﬁed, pooled together, and converted into
square millimeters. The myocyte area was then
divided by the total area of the newly formed tissue.
Similarly, the expression of the remodeling marker
matrix metalloproteinase 1, the ﬁbrotic protein dis-
coidin domain-containing receptor 2, and the prolif-
eration marker Ki67 were quantiﬁed using the same
analytic method. Moreover, the isolectin-stained
samples were used to measure the thickness of the
endocardium that developed in the graft tissue of the
seeded and unseeded patches after 4.5 months in vivo.
The endocardium thickness of the native tissue was
used as a positive control.
FLUORESCENT IN SITU HYBRIDIZATION. Parafﬁn-
embedded tissues were deparafﬁnized, rehydrated,
and allowed to air-dry. Slides were incubated with
30% sodium bisulﬁte (Sigma-Aldrich) for 20 min at
37C and washed with 2 SSC (Thermo Fisher Scien-
tiﬁc). Samples were incubated with a proteinase K
(Qiagen, Hilden, Germany) solution for 15 min at 45C
and then washed with 2 SSC. Slides were rehydrated
through an alcohol gradient and allowed to air-dry.
The Y-chromosome probe mixture (Chrombios,
Nussdorf AM Inn, Germany) was added to the sam-
ples. The slides were placed on a hotplate for 10 min
at 80C and then transferred overnight to a humidi-
ﬁed chamber at 37C. At the end of the hybridization,
the samples were washed with 0.4 SSC at 73C and
with 2 SSC at RT. Nuclei were counterstained with
40,6-diamidino-2-phenylindole (1:1,000) and moun-
ted with Vectashield Hardset Mounting Medium.
Fluorescent in situ hybridization was performed on
the seeded grafts before in vivo implantation and on
seeded grafts explanted after 24 h, 1 week, 2 weeks,
and 4.5 months. The number of cells expressing the Y
chromosome was measured in the seeded grafts
before implantation and after the deﬁned time points.Results were expressed as density of Y chromosome–
positive cells per square millimeter.
EFFECTS OF T-MSCs ON CMs. The in vitro prolifera-
tion and apoptosis of P0 rat CMs primary culture were
measured respectively with Cell Proliferation ELISA,
BrdU (Roche, Basel, Switzerland) and Caspase-Glo 3/7
Assay (Promega, Madison, Wisconsin). The CMs were
either cultured with the T-MSC-conditioned medium
or cocultured with the T-MSCs. Three independent
experiments were carried out. The conditioned
medium was freshly harvested from passage 2 and 3
T-MSCs, centrifuged, mixed with 1% FBS and 1% P/S
M199 at a ratio of 1:1, and added to the CMs.
Regarding the coculture condition, P0 primary cul-
ture of rat CMs was seeded in 96-well plates, onto
which cell culture inserts (CellCrown inserts, Sigma-
Aldrich) were placed and seeded with T-MSCs. CMs
cultured with 1% FBS and 1% P/S DMEM:M199 (1:1)
were used as a negative control. Twenty-four hours
after seeding, bromodeoxyuridine was added to the
cells to assess proliferation. Cells were incubated for
24 h at 37C in a CO2 incubator, and the enzyme-
linked immunosorbent assay kit was used according
to the manufacturer’s instructions. Absorbance was
measured at 450 nm using a microplate photometer
(Opsys MR, Dynex Technologies, Chantilly, Virginia).
Apoptosis was measured 48 h after seeding. Caspase
reagent was incubated with the cells for 45 min at RT.
The resulting luminescence was detected at 485 nm
by using a microplate luminometer (GloMax,
Promega).
A migration assay was performed on CMs to
investigate the effect of the T-MSCs on the migration
potential of the cardiac cells. CMs were either
cultured with the T-MSC-conditioned medium or
cocultured with the stem cells in a 24-well plate. After
conﬂuence was reached, the cell monolayer was
scratched with a P200 tip at the center of the well.
Then the cells were washed and 2 mmol/l
FIGURE 5 Evaluation of the Endothelialization and Vascularization of the Explants
(A) Scanning electron microscopic images show that the topography of the endocardial surface of the explants is composed of aligned and compacted cells. Similar cell
conﬂuency to the native tissue was detected in the unseeded and seeded patches. (B) By measuring the thickness of the endocardium of the sections stained for
isolectin B4 (Iso), we observed that the seeded group developed a thicker layer than the unseeded group (C). The explanted grafts generated a ﬁne and rich vascu-
larization shown by isolectin B4 and alpha–smooth muscle actin (aSMA) staining. However, no differences were observed between the 2 groups in terms of capillaries
and arteriole density. Scale bars, 50 mm. Dapi ¼ 40,6-diamidino-2-phenylindole; RV ¼ right ventricle.
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375hydroxyurea (Sigma-Aldrich) was added to the media.
Images were taken using a bright-ﬁeld microscope at
4. The proportion of gap closure was measured us-
ing ImageJ to calculate the area of the wound at the
time of the scratch and 14 h later. Each experiment
was performed in triplicate and repeated 3 times.
Released cytokines and growth factors were
analyzed in the secretome of T-MSCs. A customized
cytokine/chemokine multiplex kit (Millipore,Burlington, Massachusetts) composed of magnetic
beads for the detection of interleukin (IL)–1ra, IL-2, IL-
6, IL-8, interferon-g, and tumor necrosis factor–a was
used according to the manufacturer’s instructions.
The analysis was limited to 6 analytes because of the
low availability of porcine antibodies. Reading was
performed using a Luminex MAGPIX instrument
(Luminex, Austin, Texas). Standard culture medium
was used as control for data normalization.
FIGURE 6 Y Chromosome Fluorescent in Situ Hybridization of the Explanted Grafts
The male seeded cells (Y chromosome [Y chr] positive) were detected over the scaffold before implantation and after 24 h, 1 week, and 2
weeks. The number of seeded cells decreased with time in vivo. No seeded cells were observed at 4.5 months. Scale bars, 50 mm. Dapi ¼ 40,6-
diamidino-2-phenylindole.
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376STATISTICAL ANALYSIS. Data are expressed as
mean  SEM. Statistical analysis was carried out using
the Student’s t-test to determine the difference be-
tween 2 groups. Alternatively, 1-way analysis of
variance followed by Tukey post hoc testing was
applied to analyze the differences among multiple
groups. Results were considered statistically signiﬁ-
cant at p < 0.05.
RESULTS
CHARACTERIZATION OF T-MSCs. Adherent cells
from the swine thymus gland exhibited the typical
spindle-shape morphology. Flow cytometry of 4 celllines showed abundant expression of the mesen-
chymal markers CD44, CD73, CD90, and CD105 and
negativity for CD31 and CD45 (Figures 1A and 1B).
Furthermore, we conﬁrmed the ability of T-MSCs to
differentiate into mesenchymal lineages (Figure 1C).
CHARACTERIZATION OF T-MSC-ENGINEERED
SIS-ECM SCAFFOLDS. The T-MSCs seeded on the
SIS-ECM scaffold were grown for 1 week under static
condition and then 1 week under dynamic condition
in a bioreactor (Figure 2A). T-MSCs were viable within
the scaffold at 2 weeks from seeding, with only a few
dead cells being observed (4.0  0.6% of total cell
counts) (Figure 2B). They were stratiﬁed on the
FIGURE 7 Evaluation of Proliferating Cells in Vivo
(A) Immunostaining for Ki67 and isolectin B4 (Iso), smooth muscle myosin heavy chain (sm-MYH), a–sarcomeric actinin (aSA), and vimentin (Vim) in the seeded grafts
explanted at 24 h, 1 week, and 2 weeks. Coexpression of Ki67 with Iso and Vim suggests that the proliferating cells at early stages consist of endothelial cells (ECs) and
ﬁbroblasts. Scale bars, 50 mm. (B) The numbers of proliferating ECs and ﬁbroblasts increase after 1 week in vivo, with the ﬁbroblasts showing an increased proliferation
also after 2 weeks. (C) Double staining for Ki67 and Iso, sm-MYH, aSA, and Vim in the unseeded and seeded grafts explanted at 4.5 months. Cells coexpressing Ki67
with Iso, sm-MYH, and Vim were detected in the grafts, suggesting that the proliferating cells are ECs, vascular smooth muscle cells (VSMCs), and ﬁbroblasts. Scale
bars, 50 mm. (D) The number of Ki67-positive cells seemed to be the same between the unseeded and seeded groups 4.5 months after implantation.
Continued on the next page
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377surface of the scaffold (hematoxylin and eosin stain-
ing) and interposed with newly formed collagen
(elastic van Gieson staining). Scanning electron mi-
croscopy conﬁrmed the presence of a conﬂuent andoriented layer of cells on the surface of the SIS-ECM
scaffold.
Next, we compared the mechanical characteristics
of the unseeded and T-MSC-seeded scaffolds. No
FIGURE 7 Continued
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378difference between groups was observed with regard
to stiffness or tensile stress at maximum load (p ¼
0.1075 and p ¼ 0.2890, respectively) (Figure 2C).
FEASIBILITY AND SAFETY OF T-MSC-ENGINEERED
GRAFTS IMPLANTATION. Figure 3A illustrates the
topography (i) and operative characteristics of the
RVOT lesion (ii–iv). All operated animals survived the
surgical procedure and recovered well, with no loss
during follow-up and similar body weight gain
(Figure 3B). At termination, body weight was similar to
that of unoperated swine of the same age (91  6 kgand 93  7 kg, respectively, in the unseeded and
seeded groups vs. 90  1 kg in control groups). Echo-
cardiography showed similar values of RVOT di-
ameters (control subject vs. unseeded; p ¼ 0.1726;
control subject vs. seeded; p ¼ 0.995), left ventricular
contractile function, and left ventricular volumes
among unoperated, unseeded, and T-MSC-seeded
groups (Figure 3C, Table 2). Likewise, Doppler analysis
demonstrated no change in maximum RVOT velocity
between the control subject and operated animals
(control subject vs. unseeded; p ¼ 0.1569; control
FIGURE 8 in Vitro Assessment of the Paracrine Effect of the Thymus-Derived Mesenchymal Stem Cells
(A) Evaluation of the proliferation and apoptosis of rat cardiomyocytes (rCMs) cultured in the presence of thymus-derived mesenchymal stem cells (T-MSCs)
or with their conditioned medium showed that the presence of the stem cells stimulates the proliferation of the cardiomyocytes (CMs), without affecting
apoptosis (n ¼ 3). (B) A migration assay of the rCMs either cultured with the conditioned medium or cocultured with the T-MSCs demonstrated that the stem
cells can promote the migration of the CMs. The proportion of gap closure 14 h following the scratch was greater in the cocultured condition compared with
the control. (C) Analysis of the cytokines and growth factors released by the T-MSCs showed secretion of interleukin (IL)–1ra, IL-2, and IL-6 and a high level
of IL-8. Absence of interferon (INF)-g and tumor necrosis factor (TNF)–a was observed in the porcine T-MSC (pT-MSC)–conditioned medium.
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380subject vs. seeded; p ¼ 0.052) (Figure 3C). Similarly,
the proportion of right ventricular (RV) fractional area
change did not differ between groups and was within
clinical reference range (32% to 60%) of normal RV
function (Table 2).
IMPLANTATION OF T-MSC-ENGINEERED GRAFTS
IMPROVES RVOT CONTRACTILITY COMPARED WITH
UNSEEDED GRAFTS. Cardiac cardiac magnetic reso-
nance assessments of RVOT motion and deformation
were carried out before surgery and at termination,
using unoperated adult pigs as control subjects for
the latter time point (Figure 3D). Basal RVOT-MS
values did not differ between the study groups, thus
excluding a chance of imbalance that may inﬂuence
outcome, and were therefore cumulated (Table 3). At
the ﬁnal measurement, unseeded animals showed
reduced RVOT-MS compared with unoperated control
subjects (p < 0.05), with this gap being totally abro-
gated in the T-MSC-seeded group (control subject vs.
unseeded; p ¼ 0.1835; control subject vs. seeded; p ¼
0.0432; unseeded vs. seeded; p ¼ 0.0408) (Figure 3E).
The RVOT-MS increase observed in the seeded group
was the consequence of a reduction of the systolic
area, whereas diastolic area did not differ between the
2 groups (Table 3).
IN VIVO INTEGRATION AND REMODELING OF
T-MSC-ENGINEERED GRAFTS WITHIN THE HOST
CARDIAC TISSUE. The results of cardiac cardiac
magnetic resonance suggest that T-MSCs can confer
the implanted scaffold with the capacity to preserve
RVOT contractility. Therefore, we investigated the
mechanisms responsible for this beneﬁcial effect. At
macroscopic inspection, explanted RVOTs presented
a smooth luminal surface with no sign of tissue
degradation in both groups. Hematoxylin and eosin
staining showed in vivo integration of the grafts
within the neighboring myocardium (Figure 4A). The
newly formed tissue within the implants was
composed mainly of collagenous ﬁbers, as shown by
Masson’s trichrome (Figure 4B) and elastic van Gieson
(Supplemental Figure 1) staining. A close inspection
revealed only few discernible remnants of the SIS-
ECM scaffold (Figure 4C), suggesting that the
implanted graft underwent remodeling and new tis-
sue formation. Moreover, von Kossa staining showed
no calciﬁcation in the explanted cell-seeded or un-
seeded grafts (Figure 4C, Supplemental Figure 2).
Interestingly, the amount of collagen developed in
the cell-seeded explants was signiﬁcantly lower
compared with the unseeded explants (53.31  2.07%
and 58.45  1.36% of total section area, respectively;
p ¼ 0.0429) (Figure 4D). Immunostaining and quan-
tiﬁcation of the remodeling marker matrix metal-
loproteinase 1 demonstrated similar expression in theunseeded and seeded groups (5.91  0.32% and
6.67  0.25%, respectively; p ¼ 0.0516) (Figure 4E).
Moreover, discoidin domain-containing receptor 2
was signiﬁcantly down-regulated in the cell-seeded
compared with the unseeded group (22.5  0.64%
vs. 24.7  0.73%, respectively; p ¼ 0.0422) (Figure 4F),
which, together with the data of collagen content,
suggests an antiﬁbrotic effect that was exerted by
T-MSCs. The control RV tissue distant from the
implant was negative for the matrix metalloproteinase
1 and discoidin domain-containing receptor 2 markers.
Immunostaining for the cardiac marker cMYH
conﬁrmed the presence of myocyte-like clusters
dispersed within the explants of both unseeded and
cell-seeded groups (Figure 4G). Interestingly, the area
of the explant occupied by these myocyte-like islets
was greater in the cell-seeded group (p ¼ 0.0462).
Moreover, seeded grafts contained myocytes that
coexpress cMYH and the ventricular gap junction
protein connexin-43 (Cx-43), whereas these double-
positive myocytes were absent in unseeded grafts.
Scanning electron microscopy of the endocardial side
of the explanted grafts showed that both the un-
seeded and seeded patches developed a compact cell
layer, resembling the topography of the native tissue
(cell conﬂuence 86.12  2.39%, 86.77  1.62%, and
92.54  2.36%, respectively; unseeded vs. seeded; p ¼
0.9702; unseeded vs. RV; p ¼ 0.1598; seeded vs. RV;
p ¼ 0.2045) (Figure 5A). Immunostaining with IsoB4
demonstrated that the seeded grafts developed a
thicker layer of ECs compared with unseeded group
(53.54  2.04 and 46.45  1.81 mm, respectively; un-
seeded vs. seeded; p ¼ 0.0291; unseeded vs. RV; p ¼
0.2793; seeded vs. RV; p ¼ 0.4611) (Figure 5B).
Fluorescent microscopy identiﬁed capillaries and
arterioles within the grafts, although the former were
less abundant than in control RV myocardium, sug-
gesting that graft arteriogenesis prevailed on capil-
larization in the healing process of tissue (Figure 5C).
3The improved physiological remodeling in the
cell-seeded group prompted us to examine the fate of
the implanted male donor cells into the female re-
cipients using ﬂuorescent in situ hybridization anal-
ysis of Y chromosome in the explanted grafts. Cells
expressing the Y chromosome were detected in grafts
explanted 24 h, 1 week, and 2 weeks post-implantation
(Figure 6). We observed a progressive decline in the
abundance of cells expressing the Y chromosome, but
positive cells were still present at 2 weeks after im-
plantation (pre-operative vs. 24 h; p ¼ 0.9842;
pre-operative vs. 1 week, p¼ 0.2040; pre-operative vs.
2 weeks; p < 0.0001; 24 h vs. 1 week; p ¼ 0.03695; 24 h
vs. 2 weeks; p < 0.001; 1 week vs. 2 weeks; p ¼ 0.009).
In contrast, no Y chromosome–positive cells were
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381detected at 4.5 months. Therefore, it is most likely that
CMs and ECs found in the explanted grafts derive from
the recipient rather than from donor T-MSCs.
Next, we measured cell proliferation in grafts
explanted at 24 h, 1 week, 2 weeks, and 4.5 months by
immunostaining for Ki67, in combination with IsoB4,
smooth muscle myosin heavy chain, a–sarcomeric
actinin, and vimentin to detect, respectively, prolif-
erating ECs, vascular smooth muscle cells (VSMCs),
CMs, and ﬁbroblasts (Figure 7). Some Ki67-positive
ECs and ﬁbroblast-like cells were observed in the
seeded grafts explanted after 24 h, 1 week, and 2
weeks, whereas neither VSMCs nor CMs were positive
for Ki67 (Figure 7A). The number of proliferating ECs
increased after 1 week; likewise ﬁbroblasts showed
greater proliferation at 1 and 2 weeks compared with
24 h (ECs: 24 h vs. 1 week; p ¼ 0.0411; 24 h vs. 2
weeks; p ¼ 0.0141; 1 week vs. 2 weeks; p ¼ 0.3021;
VSMCs: 24 h vs. 1 week; p ¼ 0.4812; 24 h vs. 2 weeks,
p ¼ 0.5724; 1 week vs. 2 weeks; p ¼ 0.9839; ﬁbro-
blasts: 24 h vs. 1 week; p ¼ 0.0284; 24 h vs. 2 weeks;
p ¼ 0.0126; 1 week vs. 2 weeks; p ¼ 0.7590)
(Figure 7B). Additionally, we analyzed the prolifer-
ating cells in the seeded and unseeded grafts
explanted after 4.5 months (Figure 7C). Ki67-positive
ECs, VSMCs, and ﬁbroblasts were detected at this
time point within the grafts, but no proliferating cells
were found in the myocyte pockets, and no differ-
ences were observed regarding the number of prolif-
erating ECs, VSMCs, and ﬁbroblasts (ECs: unseeded
vs. seeded; p ¼ 0.7649; VSMCs: unseeded vs. seeded;
p ¼ 0.6262; ﬁbroblasts: unseeded vs. seeded; p ¼
0.8648) (Figure 7D).
EVALUATION OF THE PARACRINE EFFECT OF THE
T-MSCs ON THE CMs IN VITRO. To assess the
paracrine properties of T-MSCs, we measured the
proliferation and apoptosis of CMs in the presence of
T-MSCs or their conditioned medium (Figure 8A).
Results showed stimulation of CM proliferation by
T-MSCs in a coculture system (p ¼ 0.0489 vs. control),
whereas the T-MSC-conditioned medium was
ineffective (p ¼ 0.9901 vs. control). T-MSCs or their
conditioned medium did not affect CM apoptosis
(control vs, conditioned medium; p ¼ 0.2588; control
vs. coculture; p ¼ 0.1244). Therefore, continuous
production of paracrine factors by T-MSCs is indis-
pensable for induction of CM expansion in vitro.
Similarly, a migration assay of the CMs either
cultured with the T-MSC-conditioned medium or
cocultured with the T-MSCs conﬁrmed that the stem
cells have the potential to trigger the migration of
CMs in vitro (Figure 8B). Fourteen hours after the
scratch was made, the proportion of gap closure in the
coculture system was higher compared with thecontrol subject (62.18  4.69% and 51.06  2.01%,
respectively; p ¼ 0.0487 vs. control subject).
A multiplex analysis of the cytokines produced by
the T-MSCs showed that high levels of the proangio-
genic factor IL-8 are secreted by the MSCs in vitro
(Figure 8C). Relatively low levels of inﬂammatory IL-2
and IL-6 and the anti-inﬂammatory cytokine IL-1ra
were detected, whereas complete absence of proin-
ﬂammatory interferon-g and tumor necrosis factor–a
was revealed.
DISCUSSION
Because of their similarities to humans and rapid
growing rate, pigs are valuable animal models for
preclinical assessment of cardiac tissue engineering
(12,13). The present study conﬁrms the feasibility and
safety of RVOT reconstruction using a SIS-ECM graft in
growing piglets. In addition, we report for theﬁrst time
that the addition of allogeneic T-MSCs to the SIS-ECM
can upgrade the scaffold, converting it into a living
tissue, capable of remodeling and improving RVOT
contractility. Immunostaining of the explants showed
similar neovascularization but a lower degree of
ﬁbrosis and a greater abundance of mature myocytes
in the group implanted with seeded grafts. Moreover,
scanning electron microscopy and immunohisto-
chemistry analysis demonstrated a more organized
endothelialization of the T-MSC-engineered grafts.
Very few studies have focused on reconstruction of
the RVOT in animal models. Tanaka et al. (14)
implanted a SIS-ECM graft allowing the controlled
release of basic ﬁbroblast growth factor in an RVOT
porcine model. They reported the occurrence of
regional myocardial remodeling and increased tissue
viability within the patch. However, there was no
improvement in the RVOT strain. Thus, our SIS-ECM
cellularization approach seems to have a signiﬁcant
functional advantage over basic ﬁbroblast growth
factor treatment of SIS-ECM. In another study,
induced pluripotent stem cells were used to engineer a
synthetic scaffold that was implanted in the RVOT of a
rat model (3). Host CM regeneration was observed in
the cell-seeded group.
SIS-ECM material has been widely used in cardio-
vascular surgery since 2006. Early results suggested a
therapeutic potential for correction of congenital
heart defects (1,15). However, more recent data have
demonstrated less favorable clinical outcomes. For
instance, Woo et al. (16) showed a relatively high
degree of chronic inﬂammation and ﬁbrosis and poor
graft recellularization and integration with the sur-
rounding tissue in SIS-ECM specimens explanted
from pediatric patients who underwent corrective
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382heart surgery. Similar concerns were raised by studies
using SIS-ECM for valve repair in children. An intense
inﬂammatory response was observed in the sur-
rounding tissue, and little or no remodeling was
detected 9 months after implantation (17).
Our group recently showed that T-MSCs isolated
from human donors are capable to engraft and pro-
liferate onto the SIS-ECM (2). We have now estab-
lished the isolation and expansion of porcine T-MSC
lines suitable for use in an allogeneic or autologous
setting. The porcine T-MSCs displayed plastic adher-
ence, a high rate of growth, high expression of the
typical mesenchymal markers, and trilineage differ-
entiation capacity into osteocytes, adipocytes, and
chondrocytes (18). Hence, our results indicate that
the isolation of MSCs from the porcine thymus is
feasible and provides a homogenous cell population.
Successful seeding of the T-MSCs on the SIS-ECM
allowed the generation of an engineered patch
composed of a multilayer of oriented cells growing on
the surface of the scaffold. Mechanical testing of the
construct showed that T-MSC incorporation is not
detrimental to the graft physical properties. Further-
more, Y chromosome ﬂuorescent in situ hybridization
staining on seeded grafts explanted 24 h, 1 week, and
2 weeks post-operatively indicated that the donor
cells engrafted into the SIS-ECM. However, Y chro-
mosome staining on the 4.5-month explant demon-
strated no trace of the implanted cells. This implies
that the effects exerted by the cells on the sur-
rounding tissue are due mainly to a paracrine stimu-
lation that must have happened relatively soon after
implantation. In line with our results, Sugiura et al.
(3) showed that the seeded cells disappeared from the
graft 4 weeks after implantation. Nonetheless, their
early presence in vivo was sufﬁcient to favor the
regeneration of cardiac tissue.
The analysis of graft remodeling provided a
possible interpretation for the improvement of RVOT
contractility. The reduction of ﬁbrosis associated with
an increase in CMs’ number may have contributed to
rescue RVOT strain in animals implanted with T-MSC-
seeded grafts. We excluded the possibility that the
CMs colonizing the graft derived from the donor cells,
as none were found to be positive for the Y chromo-
some at the latest time point. Migration or prolifera-
tion of CMs from the neighboring myocardium could
have contributed to the muscularization of the graft.
In vitro studies showed that T-MSCs have the poten-
tial to stimulate the proliferation and migration of
neonatal CMs. However, in agreement with the
notion that adult CMs are terminally differentiated,
we did not ﬁnd any sign of CM proliferation in the
explanted grafts, the only Ki67-positive cells beingvascular and stromal cells. Therefore, CM migration
remains the most likely explanation for graft muscu-
larization in vivo. Furthermore, only seeded grafts
induced the colonization of CMs coexpressing cMYH
and Cx-43, while unseeded grafts were unable to
maintain normal RVOT strain and contained cMYH
cells negative for Cx-43. This marker has been asso-
ciated with preserved CM functionalities. For
instance, early-stage compensated left ventricular
hypertrophy is characterized by increased Cx-43
immunoﬂuorescent signal per myocyte volume and
extensive Cx-43 lateral labeling, whereas Cx-43 be-
comes down-regulated in the decompensated stage of
cardiac hypertrophy (19). Gap junctional coupling is
important for functional integration of transplanted
cells with host myocardium (20). Furthermore, non-
canonical functions of Cx-43 include the control of
sodium channels with important repercussions on the
propagation of electric activity in the heart (21).
Graft cellularization resulted in a more organized
endothelialization of the endocardial side of the graft
but did not improve revascularization at capillary or
arteriole level. Interestingly, arteriogenesis was not
associated with a robust capillarization of the graft.
Hence, it would be important to determine in the
future whether stimulation of angiogenesis could
further improve RVOT functionalization.
CONCLUSIONS
Our study indicates that functionalization of the
graft with T-MSCs may obviate the contractility and
endothelialization problems reported after surgical
correction of the RVOT (10). The addition of T-MSCs
to the SIS-ECM converted it into a living tissue,
capable of preventing the formation of an akinetic
RVOT area. Akinetic regions developed in the RVOT
have been associated with myocardial scarring,
ﬁbrosis, and electromechanical delay (22). Further-
more, abnormal ﬁbrous tissue deposition and adi-
pose tissue substitution can develop around the
surgical scar and can eventually lead to electric
instability, re-entrant arrhythmias, and even sudden
cardiac death (23,24). We did not perform electro-
physiological studies; thus, we can only infer the
absence of life-threatening arrhythmias from the fact
that no fatality was observed. Another limitation of
the study was the absence of a sham-operated group
to assess unspeciﬁc background effect of surgery on
the heart. However, the main comparator was the
group of pigs with grafts that were not seeded with
stem cells.
Most of the grafts currently used in cardiac surgery
are either synthetic or ﬁxed materials. These materials
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Our study dem-
onstrates for the ﬁrst time in a clinically relevant, randomized,
large animal study the importance of using autologous stem cell
tissue engineered patches for reconstruction of the RVOT.
TRANSLATIONAL OUTLOOK: The translation of this work
into a clinical safety and efﬁcacy study in patients with tetralogy
of Fallot can open the way to the application of personalized
grafts for reconstructive surgery in congenital heart disease,
which can grow and remodel in vivo and therefore avoid the life-
threatening complications seen in these complex patients. Our
main challenges will be to transfer the production of our tissue-
engineered grafts into clinically upgraded facilities and to iden-
tify funding for this very new and exciting “personalized”
approach for neonates and infants born with congenital heart
disease.
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383have not been proved to be particularly effective
during long-term follow-up, leading to lack of
contractility and mismatched mechanical properties,
which might contribute to the risk for sudden death
(25,26). Our feasibility, safety, and efﬁcacy in vivo
study has shown that seeding SIS-ECM with T-MSCs
overcomes some of the known limitations of current
prosthetic material. These results may pave the way to
new modalities for effective surgical restoration of RV
function in patients with tetralogy of Fallot.
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